Old Web
English
Sign In
Acemap
>
Paper
>
Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML
Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML
2016
Ulrike Tontsch-Grunt
Fabio Savarese
Anke Baum
Dirk Scharn
Daniel Gerlach
Marco H. Hofmann
Johannes Popow
Norbert Schweifer
Harald Engelhardt
Hanny Musa
Chooi Lee
Gerd Munzert
Norbert Kraut
Keywords:
Regimen
BET inhibitor
Pharmacology
Medicine
Cyclin-dependent kinase 9
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]